Home002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Nakaraang pagsara
¥39.65
Sakop ng araw
¥37.17 - ¥39.68
Sakop ng taon
¥25.51 - ¥41.27
Market cap
44.20B CNY
Average na Volume
9.22M
P/E ratio
73.45
Dividend yield
-
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.06B | -2.64% |
Gastos sa pagpapatakbo | 591.80M | 6.55% |
Net na kita | 200.33M | 0.03% |
Net profit margin | 18.86 | 2.72% |
Kita sa bawat share | — | — |
EBITDA | 298.43M | -2.46% |
Aktuwal na % ng binabayarang buwis | 11.01% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.71B | 53.81% |
Kabuuang asset | 10.66B | 10.96% |
Kabuuang sagutin | 1.70B | 26.43% |
Kabuuang equity | 8.96B | — |
Natitirang share | 1.11B | — |
Presyo para makapag-book | 4.96 | — |
Return on assets | 4.93% | — |
Return on capital | 5.79% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 200.33M | 0.03% |
Cash mula sa mga operasyon | 169.39M | -26.39% |
Cash mula sa pag-invest | 127.46M | 219.62% |
Cash mula sa financing | 16.61M | 149.11% |
Net change in cash | 311.38M | 244.57% |
Malayang cash flow | -850.75M | -46.03% |
Tungkol
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Itinatag
Nob 3, 1998
Website
Mga Empleyado
3,596
